Six New Limited Submission Opportunities for the Week of May 18, 2026
Six New Limited Submission Opportunities for the Week of May 18, 2026

Research Development Office

Funding Landscape and New Limited Submission Opportunities for the Week of May 18, 2026

Click here to share this information with department heads and eligible faculty.

Funding Landscape

The Impulse by Chiesi is seeking in utero treatments for rare diseases.
The Impulse by Chiesi is seeking innovative in utero therapeutic solutions for rare diseases. This call focuses on approaches that enable early intervention to prevent or significantly reduce disease burden before birth. Submissions are due June 10, 2026.

Stay connected with industry partnership opportunities.
Subscribe to the Inpart newsletter for weekly updates from companies seeking academic collaborators and research institution partnerships.

New Limited Submission Opportunities

NIH: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

Description: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish Lead Academic Organizations (LAOs) as part of the NCI Experimental Therapeutics Clinical Trials Network (ETCTN). ETCTN LAOs will design, develop, monitor, conduct, and analyze early phase clinical trials (e.g., phase 0, phase 1, phase 2, pilot, and other experimental therapeutic clinical trials) involving agents under regulatory sponsorship for New Investigational Drug (IND) applications held by NCI's Division of Cancer Treatment and Diagnosis (DCTD), Cancer Therapy Evaluation Program (CTEP). Each ETCTN LAO will participate in clinical trials it leads as well as clinical trials led by other LAOs in the network.
Limitation: one application per institution
Internal Submission Deadline: Friday, May 22, 2026 at 12pm
Sponsor Application Deadline: Tuesday, June 30, 2026

NIH: The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)

Description: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications from institutions/organizations that propose to maintain or establish a Pharmacokinetics Resource Laboratory (PK Laboratory) to support the Experimental Therapeutics Clinical Trials Network (ETCTN). The PK Laboratory will organize biospecimen collections and provide subsequent analyses of pharmacokinetic endpoints, drug-drug interactions, cytochrome P450 (CYP) interactions, pharmacodynamics, and food effects in ETCTN studies of NCI Investigational New Drug (IND) agents. The overarching goal of the ETCTN PK Laboratory is to advance the clinical development of NCI IND agents by providing a comprehensive understanding of pharmacokinetic behavior of these agents under study in ETCTN trials. 
Limitation: one application per institution 
Internal Submission Deadline: Friday, May 22, 2026 at 12pm
Sponsor Application Deadline: Tuesday, June 30, 2026

NIH: Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

Description: The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine.
Limitation: one application per institution
Internal Submission Deadline: Tuesday, May 26, 2026
Sponsor Application Deadline: Thursday, July 9, 2026

NIH: Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)

Description: The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.
Limitation: one application per institution
Internal Submission Deadline: Tuesday, May 26, 2026
Sponsor Application Deadline: Friday, July 10, 2026

Department of Education: Personnel Preparation of Special Education, Early Intervention, and Related Services Personnel

Description: The purposes of the Personnel Development to Improve Services and Results for Children with Disabilities program are to 1. help address State identified shortages and needs for personnel preparation in special education and early intervention, including infants and toddlers, and youth with disabilities; and 2. ensure that those personnel have the necessary skills and knowledge, derived from practices that have been determined through scientifically based research, to be successful in serving those children. 
Limitation: one application per institution
Internal Submission Deadline: Wednesday, May 27, 2026
Sponsor Application Deadline: Thursday, July 2, 2026

DOE/TechWerx: Partnerships for Academic-Industry Career Training (PACT) Initiative

Description: U.S. Department of Energy’s (DOE) Hydrocarbons and Geothermal Energy Office (HGEO) and Office of Indian Energy Policy and Programs (IE) are soliciting applications from institutions of higher education (IHEs) through the Partnerships for Academic-Career Training (PACT) Initiative. The goal of the PACT initiative is to increase the number of highly skilled individuals entering the American energy workforce. 
Limitation: one application per institution
Internal Submission Deadline: Monday, June 1, 2026
Sponsor Application Deadline: Friday, July 17, 2026

The University of Iowa